SIMVACOR

This brand name is authorized in Estonia, Hong Kong, Israel, Lithuania, Malta, Poland, Singapore, South Africa

Active ingredients

The drug SIMVACOR contains one active pharmaceutical ingredient (API):

1 Simvastatin UNII AGG2FN16EV - SIMVASTATIN

Simvastatin has a potent activity in inhibiting HMG-CoA reductase (3-hydroxy–3-ethylglutaryl-CoA-reductase). Simvastatin has been shown to reduce both normal and elevated LDL-C concentrations. Read about Simvastatin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AA01	Simvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1080166, 1080177, 1129700, 1142491, 1142503, 1142514, 1142525, 1142536, 1142547, 1621493
Country: HK	Department of Health Drug Office	Identifier(s): 55334
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3863, 3864, 3865
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003683, 1003684
Country: MT	Medicines Authority	Identifier(s): MA122/02401
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100112670, 100112687
Country: SG	Health Sciences Authority	Identifier(s): 12448P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 35/7.5/0237, 35/7.5/0238, A39/7.5/0132